Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population.

Diabetes is associated with higher sNfL. Further large-scale and prospective studies are needed to replicate our results and evaluate the ability of sNfL to predict the incidence of neuropathy and dementia in this patient population.